Baxter International Inc. company logo

# 1st Gen Model Baxter International Inc. Surgical & medical instruments

  • $60.69Last close price
    at 27-jun-2017
  • Subscribe >> Deal exit on
    June 28, 2017
    Deal entry on
    June 28, 2017
  • 1.28%Expected margin
  • 48.05% successful of 77 deals

BAX

Model's trade recommendations -1.79% Return for period

-17.22% Annual return

$33.15B Market Cap

β 0.68  

BAX

Model (following trade recommendations)

BAX

Underlying stock

S&P 500

Index
Return for period -1.79%
2.33%
1.78%
52wk return -16.41%
39.90%
16.82%
52wk Range
43.38—61.38
2000.54—2399.63
Sortino ratio -1.82
Sharpe ratio -1.62
Norm. RMSE 0.39%
Downside risk 10.20%
Volatility 11.47%
  • 0.64 (1.05%) Div (Yield)
  • HOLD Analysts consensus recommendation

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Baxter International Inc. (BAX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for BAX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 543M
P/E 28.10
Shares Outstanding 544M
% Held by Insiders 0.05%
% Held by Institutions 83.90%
EPS (last reported FY) $1.96
EPS (last reported Q) $0.58
EPS, estimated (last reported Q) $0.51
Total revenues $10 B
Net income $5 B